National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 984515

Government Disclaimer on use of this data

History of Changes from the VAERS Wayback Machine

First Appeared on 4/16/2021

VAERS ID: 984515
VAERS Form:2
Age:45.0
Sex:Female
Location:D.C.
Vaccinated:2021-01-14
Onset:2021-01-15
Submitted:0000-00-00
Entered:2021-01-29
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL1284 / 1 LA / OT

Administered by: Private      Purchased by: ??
Symptoms: Blister, Burning sensation, Petechiae, Skin discolouration, Limb injury, SARS-CoV-2 test

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: PLAQUENIL [HYDROXYCHLOROQUINE SULFATE]; LEFLUNOMIDE; RESTASIS; PILOCARPINE; VITAMIN D [COLECALCIFEROL]; OMEGA 3 [FISH OIL]
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Abdominal hysterectomy; Bilateral salpingo-oophorectomy; Ovarian stromal cancer; Raynauds; Sjogren''s; Sulfonamide allergy
Allergies:
Diagnostic Lab Data: Test Date: 20210115; Test Name: Covid PCR Test (Nasal Swab); Test Result: Negative
CDC 'Split Type': USPFIZER INC2021042364

Write-up: petechiae with discoloration; petechiae with discoloration; L 2nd MTP and R 3rd MTP burning sensation; foot blister; stubbed a toe; This is a spontaneous report from a contactable nurse (patient). A 45-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=EL1284) at Left arm, intramuscular on 14Jan2021 16:45 at single dose for covid-19 immunisation. Medical history included Sjogren''s, Raynaud, s/p Total abdominal hysterectomy (TAH)/Bilateral salpingo-oophorectomy (BSO) sex cord sclerosing stromal tumor, and known allergies: Sulfa. Patient did not have Covid prior vaccination. Concomitant medication included hydroxychloroquine sulfate (PLAQUENIL), leflunomide, ciclosporin (RESTASIS), pilocarpine, colecalciferol (VITAMIN D), fish oil (OMEGA 3). Since the 14Jan2021 Pfizer COVID vaccine, the patient had left (L) 2nd Metatarsophalangeal (MTP) and right (R) 3rd MTP burning sensation on 15Jan2021 10:00 (like she had foot blister or stubbed a toe). Then, she had petechiae with discoloration on 16Jan2021 and 17Jan2021. No treatment was received for the events. The patient lab data included Covid PCR Test (Nasal Swab): negative on 15Jan2021. The outcome of events was recovering.


Changed on 5/7/2021

VAERS ID: 984515 Before After
VAERS Form:2
Age:45.0
Sex:Female
Location:D.C.
Vaccinated:2021-01-14
Onset:2021-01-15
Submitted:0000-00-00
Entered:2021-01-29
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL1284 / 1 LA / OT

Administered by: Private      Purchased by: ??
Symptoms: Blister, Burning sensation, Petechiae, Skin discolouration, Limb injury, SARS-CoV-2 test

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: PLAQUENIL [HYDROXYCHLOROQUINE SULFATE]; LEFLUNOMIDE; RESTASIS; PILOCARPINE; VITAMIN D [COLECALCIFEROL]; OMEGA 3 [FISH OIL]
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Abdominal hysterectomy; Bilateral salpingo-oophorectomy; Ovarian stromal cancer; Raynauds; Sjogren''s; Sulfonamide allergy
Allergies:
Diagnostic Lab Data: Test Date: 20210115; Test Name: Covid PCR Test (Nasal Swab); Test Result: Negative
CDC 'Split Type': USPFIZER INC2021042364

Write-up: petechiae with discoloration; petechiae with discoloration; L 2nd MTP and R 3rd MTP burning sensation; foot blister; stubbed a toe; This is a spontaneous report from a contactable nurse (patient). A 45-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=EL1284) at Left arm, intramuscular on 14Jan2021 16:45 at single dose for covid-19 immunisation. Medical history included Sjogren''s, Raynaud, s/p Total abdominal hysterectomy (TAH)/Bilateral salpingo-oophorectomy (BSO) sex cord sclerosing stromal tumor, and known allergies: Sulfa. Patient did not have Covid prior vaccination. Concomitant medication included hydroxychloroquine sulfate (PLAQUENIL), leflunomide, ciclosporin (RESTASIS), pilocarpine, colecalciferol (VITAMIN D), fish oil (OMEGA 3). Since the 14Jan2021 Pfizer COVID vaccine, the patient had left (L) 2nd Metatarsophalangeal (MTP) and right (R) 3rd MTP burning sensation on 15Jan2021 10:00 (like she had foot blister or stubbed a toe). Then, she had petechiae with discoloration on 16Jan2021 and 17Jan2021. No treatment was received for the events. The patient lab data included Covid PCR Test (Nasal Swab): negative on 15Jan2021. The outcome of events was recovering.


Changed on 5/14/2021

VAERS ID: 984515 Before After
VAERS Form:2
Age:45.0
Sex:Female
Location:D.C.
Vaccinated:2021-01-14
Onset:2021-01-15
Submitted:0000-00-00
Entered:2021-01-29
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL1284 / 1 LA / OT

Administered by: Private      Purchased by: ??
Symptoms: Blister, Burning sensation, Petechiae, Skin discolouration, Limb injury, SARS-CoV-2 test

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: PLAQUENIL [HYDROXYCHLOROQUINE SULFATE]; LEFLUNOMIDE; RESTASIS; PILOCARPINE; VITAMIN D [COLECALCIFEROL]; OMEGA 3 [FISH OIL]
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Abdominal hysterectomy; Bilateral salpingo-oophorectomy; Ovarian stromal cancer; Raynauds; Sjogren''s; Sulfonamide allergy
Allergies:
Diagnostic Lab Data: Test Date: 20210115; Test Name: Covid PCR Test (Nasal Swab); Test Result: Negative
CDC 'Split Type': USPFIZER INC2021042364

Write-up: petechiae with discoloration; petechiae with discoloration; L 2nd MTP and R 3rd MTP burning sensation; foot blister; stubbed a toe; This is a spontaneous report from a contactable nurse (patient). A 45-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=EL1284) at Left arm, intramuscular on 14Jan2021 16:45 at single dose for covid-19 immunisation. Medical history included Sjogren''s, Raynaud, s/p Total abdominal hysterectomy (TAH)/Bilateral salpingo-oophorectomy (BSO) sex cord sclerosing stromal tumor, and known allergies: Sulfa. Patient did not have Covid prior vaccination. Concomitant medication included hydroxychloroquine sulfate (PLAQUENIL), leflunomide, ciclosporin (RESTASIS), pilocarpine, colecalciferol (VITAMIN D), fish oil (OMEGA 3). Since the 14Jan2021 Pfizer COVID vaccine, the patient had left (L) 2nd Metatarsophalangeal (MTP) and right (R) 3rd MTP burning sensation on 15Jan2021 10:00 (like she had foot blister or stubbed a toe). Then, she had petechiae with discoloration on 16Jan2021 and 17Jan2021. No treatment was received for the events. The patient lab data included Covid PCR Test (Nasal Swab): negative on 15Jan2021. The outcome of events was recovering.

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=984515&WAYBACKHISTORY=ON


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166